Annual Accounts Receivable
$19.69 M
-$2.77 M-12.32%
December 31, 2024
Summary
- As of March 11, 2025, YMAB annual accounts receivable is $19.69 million, with the most recent change of -$2.77 million (-12.32%) on December 31, 2024.
- During the last 3 years, YMAB annual accounts receivable has risen by +$11.98 million (+155.29%).
- YMAB annual accounts receivable is now -12.32% below its all-time high of $22.45 million, reached on December 31, 2023.
Performance
YMAB Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$19.69 M
-$228.00 K-1.14%
December 31, 2024
Summary
- As of March 11, 2025, YMAB quarterly accounts receivable is $19.69 million, with the most recent change of -$228.00 thousand (-1.14%) on December 31, 2024.
- Over the past year, YMAB quarterly accounts receivable has stayed the same.
- YMAB quarterly accounts receivable is now -12.32% below its all-time high of $22.45 million, reached on December 31, 2023.
Performance
YMAB Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
YMAB Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.3% | 0.0% |
| 3 y3 years | +155.3% | +57.1% |
| 5 y5 years | - | +57.1% |
YMAB Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.3% | +155.3% | -12.3% | +173.1% |
| 5 y | 5-year | -12.3% | -100.0% | -12.3% | -100.0% |
| alltime | all time | -12.3% | -100.0% | -12.3% | -100.0% |
Y-mAbs Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $19.69 M(-12.3%) | $19.69 M(-1.1%) |
| Sep 2024 | - | $19.92 M(-10.3%) |
| Jun 2024 | - | $22.19 M(+7.8%) |
| Mar 2024 | - | $20.59 M(-8.3%) |
| Dec 2023 | $22.45 M(+79.2%) | $22.45 M(+19.0%) |
| Sep 2023 | - | $18.87 M(-1.3%) |
| Jun 2023 | - | $19.12 M(+2.2%) |
| Mar 2023 | - | $18.70 M(+49.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $12.53 M(+62.5%) | $12.53 M(+35.5%) |
| Sep 2022 | - | $9.25 M(+28.3%) |
| Jun 2022 | - | $7.21 M(-22.7%) |
| Mar 2022 | - | $9.32 M(+20.9%) |
| Dec 2021 | $7.71 M(>+9900.0%) | $7.71 M(+6.2%) |
| Sep 2021 | - | $7.26 M(-14.7%) |
| Jun 2021 | - | $8.52 M(+42.0%) |
| Mar 2021 | - | $6.00 M(>+9900.0%) |
| Dec 2020 | $0.00 | $0.00 |
FAQ
- What is Y-mAbs Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual accounts receivable year-on-year change?
- What is Y-mAbs Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly accounts receivable year-on-year change?
What is Y-mAbs Therapeutics annual accounts receivable?
The current annual accounts receivable of YMAB is $19.69 M
What is the all time high annual accounts receivable for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual accounts receivable is $22.45 M
What is Y-mAbs Therapeutics annual accounts receivable year-on-year change?
Over the past year, YMAB annual accounts receivable has changed by -$2.77 M (-12.32%)
What is Y-mAbs Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of YMAB is $19.69 M
What is the all time high quarterly accounts receivable for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly accounts receivable is $22.45 M
What is Y-mAbs Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, YMAB quarterly accounts receivable has changed by $0.00 (0.00%)